A Study Evaluating the Safety of the Nasal Pump

Phase 4TerminatedNCT06329687

Oyster Point Pharma, Inc.5 enrolled

Overview

The objective of this study is to determine the safety of the Tyrvaya nasal pump.

The study is testing the hypothesis that the use of the Tyrvaya nasal pump with silicone lubricant does not introduce any additional safety concerns as compared to the safety of the Tyrvaya nasal pump without the additional silicone lubricant.

Study Type

INTERVENTIONAL

Allocation

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Dry Eye Kerato Conjunctivitis Sicca

Interventions

Tyrvaya Nasal PumpDRUG

Tyrvaya Nasal Pump with Silicone Lubricant

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Be at least 18 years of age * Have provided verbal and written informed consent * Willing to comply with all study related visits and procedures Exclusion Criteria: * Be currently enrolled in an investigational drug or device study or have used an investigational drug or device within 30 days prior to Visit 1.

Locations (1)

United States, California

Newport Beach, California, United States

Outcomes

Primary Outcomes

Number of Participants With Adverse Events

Number of Participants with Adverse Events with the nasal pump with additional silicone lubricant

Time frame: 7 days

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.